Richard Weisler, MD
Richard Weisler, MD
University of North Carolina at Chapel Hill
- Consultant: Alcobra Pharma; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb; Dainippon Sumitomo Pharma America, Inc./Sunovion; Forest Laboratories, Inc.; Ingenuity Health; Otsuka America Pharmaceutical, Inc.; ProPhase Labs, Inc.; Shire Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Validus Pharmaceuticals LLC
- Research Support: Alcobra Pharma; Bristol-Myers Squibb; Dainippon Sumitomo Pharma America, Inc./Sunovion; Elan; Hoffmann-La Roche Inc.; Merck & Co., Inc.; Otsuka America Pharmaceutical, Inc.; Shire Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.
- Speakers Bureau: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb; Dainippon Sumitomo Pharma America, Inc./Sunovion; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Otsuka America Pharmaceutical, Inc.; Shire Pharmaceuticals, Inc.; Validus Pharmaceuticals LLC
- Stock or Equity: Cortex Pharmaceuticals, Inc.; Merck & Co., Inc.; Pfizer Inc.